Private philanthropy provides venture capital that is essential to the progress of medical research. Although they are heterogeneous and the support they provide is small in comparison to governmental and industrial support, philanthropic foundations fill a crucial, catalytic niche in medical research, and their involvement in this area should be extended. Foundations and the scientific community should pursue policies augmenting private contributions, and they should educate potential donors a
 |
Total philanthropic giving for 1997 came to $143.46 billion, with $121.89 billion from individuals and bequests, $13.37 billion from noncorporate foundations, and $8.2 billion from corporate foundations. Just over $14 billion, or 8.8 percent of total contributions received by charities, was in the health category. This segment included support of health services and health facilities, such as hospitals and nursing homes; support of ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
